Co-clustering is a widely used technique that allows the analysis of complex and high-dimensional data in various domains. However, existing models mostly concentrate on continuous and dense data in fixed time situations, where cluster assignments remain unchanged over time. For example, in the field of pharmacovigilance, it is crucial to...
-
January 15, 2024 (v1)PublicationUploaded on: January 22, 2024
-
March 29, 2023 (v1)Journal article
Objectives Maximum a posteriori Bayesian estimation (MAP-BE) based on a limited sampling strategy and a population pharmacokinetic (POPPK) model is used to estimate individual pharmacokinetic parameters. Recently, we proposed a methodology that combined population pharmacokinetic and machine learning (ML) to decrease the bias and imprecision in...
Uploaded on: February 4, 2024 -
July 21, 2023 (v1)Journal article
Abstract Introduction Tacrolimus is an immunosuppressant largely used in heart transplantation. However, the calculation of its exposure based on the area under the curve (AUC) requires the use of a population pharmacokinetic (PK) model. The aims of this work were (i) to develop a population PK model for tacrolimus in heart transplant patients,...
Uploaded on: September 5, 2023 -
September 1, 2024 (v1)Journal article
The use of synthetic data in pharmacology research has gained significant attention due to its potential to address privacy concerns and promote open science. In this study, we implemented and compared three synthetic data generation methods, CT-GAN, TVAE, and a simplified implementation of Avatar, for a previously published pharmacogenetic...
Uploaded on: October 23, 2024 -
October 2023 (v1)Journal article
International audience
Uploaded on: December 6, 2023 -
June 13, 2024 (v1)Journal article
Pseudoxanthoma elasticum (PXE) is a rare inherited systemic disease responsible for a juvenile peripheral arterial calcification disease. The clinical diagnosis of PXE is only based on a complex multi-organ phenotypic score and/or genetical analysis. Reduced plasma inorganic pyrophosphate concentration [PPi]p has been linked to PXE. In this...
Uploaded on: July 27, 2024 -
September 2023 (v1)Journal article
Eating disorders, characterized by abnormal eating, weight control behaviors or both include anorexia nervosa (AN) and bulimia nervosa (BN). We investigated their potential iatrogenic triggers, using real-world data from the WHO safety database (VigiBase®). VigiBase® was queried for all AN and BN reports. The reports were classified as...
Uploaded on: September 5, 2023 -
July 12, 2023 (v1)Journal article
Migraine constitutes the world's second-leading cause of disability. Triptans, as serotonin 5-HT1B/1D receptor agonists, remain the first-line treatment, despite discouraged use in individuals at high cardiovascular risk. Lasmiditan, a selective lipophilic 5-HT1F agonist without vasoconstrictive effects, is an emerging option. We aimed to...
Uploaded on: September 5, 2023 -
April 2024 (v1)Journal article
International audience
Uploaded on: July 27, 2024 -
March 16, 2024 (v1)Journal article
International audience
Uploaded on: July 27, 2024 -
March 16, 2024 (v1)Journal article
Background and objectives: Ganciclovir (GCV) and valganciclovir (VGCV) show large interindividual pharmacokinetic variability, particularly in children. The objectives of this study were (1) to develop machine learning (ML) algorithms trained on simulated pharmacokinetics profiles obtained by Monte Carlo simulations to estimate the best...
Uploaded on: September 19, 2024 -
March 16, 2024 (v1)Journal article
Background and objectives: Ganciclovir (GCV) and valganciclovir (VGCV) show large interindividual pharmacokinetic variability, particularly in children. The objectives of this study were (1) to develop machine learning (ML) algorithms trained on simulated pharmacokinetics profiles obtained by Monte Carlo simulations to estimate the best...
Uploaded on: January 13, 2025 -
March 16, 2024 (v1)Journal article
Background and objectives: Ganciclovir (GCV) and valganciclovir (VGCV) show large interindividual pharmacokinetic variability, particularly in children. The objectives of this study were (1) to develop machine learning (ML) algorithms trained on simulated pharmacokinetics profiles obtained by Monte Carlo simulations to estimate the best...
Uploaded on: January 13, 2025 -
July 31, 2024 (v1)Journal article
International audience
Uploaded on: August 2, 2024 -
September 30, 2024 (v1)Journal article
Purpose of review This review summarizes available data for lenacapavir, an investigational first-in-class agent that disrupts functioning of HIV capsid protein across multiple steps in the viral life cycle. Recent findings Lenacapavir demonstrated picomolar potency in vitro with no cross resistance to existing antiretroviral classes and potent...
Uploaded on: October 26, 2024 -
May 2, 2024 (v1)Journal article
ABSTRACT Daptomycin is a concentration-dependent lipopeptide antibiotic for which exposure/effect relationships have been shown. Machine learning (ML) algorithms, developed to predict the individual exposure to drugs, have shown very good performances in comparison to maximum a posteriori Bayesian estimation (MAP-BE). The aim of this work was...
Uploaded on: July 27, 2024 -
February 8, 2024 (v1)Journal article
Abstract Aims Monitoring drug safety in real‐world settings is the primary aim of pharmacovigilance. Frequent adverse drug reactions (ADRs) are usually identified during drug development. Rare ones are mostly characterized through post‐marketing scrutiny, increasingly with the use of data mining and disproportionality approaches, which lead to...
Uploaded on: July 27, 2024 -
2025 (v1)Journal article
Background: Transplant recipients face increased cancer mortality due to immunosuppressive treatments. Immune checkpoint inhibitors (ICI) have improved survival rates, but data on the use of these agents in transplant recipients is scarce. ICI may trigger allograft rejection, but the absolute risk of AR between the different ICI classes remains...
Uploaded on: April 4, 2025